previous compound ID: 1943 next compound
InChIKey: RHKZVMUBMXGOLL-UHFFFAOYSA-N
SMILES: CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "DY Thomas" "J Goepp" "E Matthes" "B Kus" "J Liao" "JW Hanrahan" "R Robert" "GW Carlile" "D Rotin"

chemical graph of compound 1943





CID is 22162
synonyms found at PubChem are:
CYCLOPENTOLATE HYDROCHLORIDE, 5870-29-1, Cyclopentolate HCL, AK-Pentolate, Akpentolate, Cyplegin, Pentolair, Zyklolat, 2-(Dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride, EINECS 227-521-8, MLS000069583, CHEBI:4025, beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate hydrochloride, 2-(Dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride, SMR000058810, 2-(2-(1-Hydroxycyclopentyl)-2-phenylacetoxy)ethyldimethylammonium chloride, 2-(Dimethylamino)ethyl (+-)-1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride, DSSTox_CID_25390, DSSTox_RID_80847, DSSTox_GSID_45390, Cicloplegicedol, Ciclolux, Skiacol, Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride, Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester, hydrochloride, Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride, (+-)-, Mydplegic, Alnide, SR-01000003121, CyclopentolateHCl, 2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;hydrochloride, Cyclogyl (TN), Cyclopentolate hydrochloride [USP:JAN], Opera_ID_69, Cyclopentolate hydrochloride [USAN:JAN], AC1L2JUE, NCGC00016661-01, (+-)-cyclopentolate HCl, CAS-5870-29-1, Benzeneacetic acid, ?-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride, SCHEMBL24612, MLS001148637, MLS001332539, MLS001332540, SPECTRUM1500212, REGID_for_CID_22162, CHEMBL1200473, DTXSID9045390, HMS1571K12, HMS1920A22, Pharmakon1600-01500212, BCP21337, (+/-)-Cyclopentolate Hydrochloride, Cyclopentolate for system suitability, Tox21_110550, CC0260, CCG-39635, NSC756706, 2- ethyl - phenylacetatehydrochloride, AKOS015901379, Tox21_110550_1, NSC-756706, Cyclopentolate hydrochloride (JP17/USP), NCGC00018213-06, NCGC00094635-01, NCGC00094635-02, NCGC00094635-03, NCGC00094635-04, 5870-29-1 (HCl), AC-27486, AN-20017, AS-49330, LS-57811, SC-81592, FT-0603161, ST24039645, Y0424, D01002, 870C291, SR-01000003121-4, I14-15042, 2-(dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate hydrochloride, 2-(Dimethylamino)ethyl 1-Hydroxy-|A-phenylcyclopentaneacetate Hydrochloride, 2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride, Cyclopentolate hydrochloride, European Pharmacopoeia (EP) Reference Standard, 2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate hydrochloride, 2-Dimethylaminoethyl 1-hydroxy-|A-phenylcyclopentaneacetate,Cyclopentolate hydrochloride, Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester,hydrochloride, Cyclopentolate for system suitability, European Pharmacopoeia (EP) Reference Standard, Cyclopentolate hydrochloride, United States Pharmacopeia (USP) Reference Standard, AC1LCW6R, 2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate; hydron; chloride, 2-(dimethylamino)ethyl 2-(hydroxycyclopentyl)-2-phenylacetate, chloride, SBB057414, AKOS024366250, MCULE-2908399106, ST50999672